Biles Brian, Nicholas Lauren Hersch, Cooper Barbara S
Department of Health Policy, George Washington University School of Public Health and Health Services, USA.
Issue Brief (Commonw Fund). 2004 May(750):1-12.
The recently enacted Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) includes a broad set of provisions intended to enlarge the role of private health plans (called Medicare Advantage plans) in Medicare. This issue brief examines the payments that private plans are receiving in 2004 relative to costs in traditional fee-for-service Medicare, using data from the 2004 Medicare Advantage Rate Calculation Data spreadsheet. The authors find that, for 2004, Medicare Advantage payments will average 8.4 percent more than costs in traditional fee-for-service Medicare: $552 for each of the 5 million Medicare enrollees in managed care, for a total of more than $2.75 billion. In some counties, extra payments by Medicare are more than double this amount. Although the stated objective of efforts to increase enrollment in private plans is to lower costs, the policies of MMA regarding private plans explicitly increase Medicare costs in 2004 and through 2013.
最近颁布的2003年《医疗保险处方药、改进与现代化法案》(MMA)包含一系列广泛的条款,旨在扩大私人健康计划(称为“医疗保险优势计划”)在医疗保险中的作用。本问题简报利用2004年医疗保险优势费率计算数据电子表格中的数据,研究了2004年私人计划相对于传统按服务付费医疗保险成本所获得的支付情况。作者发现,2004年,医疗保险优势计划的支付平均比传统按服务付费医疗保险的成本高出8.4%:对于参加管理式医疗的500万医疗保险参保人,每人552美元,总计超过27.5亿美元。在一些县,医疗保险的额外支付超过这一数额的两倍。尽管增加私人计划参保人数的既定目标是降低成本,但MMA有关私人计划的政策在2004年至2013年期间明确增加了医疗保险成本。